Longitude Capital Partners V, LLC 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:46 pm Purchase | 2026-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | Longitude Capital Partners V, LLC | 15,288,461 7.000% | 3,750,000 (+32.50%) | Filing |
| 2025-05-20 9:00 pm Purchase | 2025-05-13 | 13G | CYTOMX THERAPEUTICS INC CTMX | Longitude Capital Partners V, LLC | 11,538,461 7.300% | 11,538,461 (New Position) | Filing |